Pegylated interferon alpha 2a is an effective and well‐tolerated treatment option for lymphocyte‐variant hypereosinophilic syndrome. (13th November 2019)

Record Type:: Journal Article
Title:: Pegylated interferon alpha 2a is an effective and well‐tolerated treatment option for lymphocyte‐variant hypereosinophilic syndrome. (13th November 2019)
Main Title:: Pegylated interferon alpha 2a is an effective and well‐tolerated treatment option for lymphocyte‐variant hypereosinophilic syndrome
Authors:: Choi, Charles
Moller, Daniel
Tan, Julia
Dou, Carol
Peterson, Erica A.
Medvedev, Nadia
Dutz, Jan P
Carruthers, Mollie N.
Chen, Luke Y. C.
Abstract:
Is Part Of:: British journal of haematology. Volume 188:Number 5(2020)
Journal:: British journal of haematology
Issue:: Volume 188:Number 5(2020)
Issue Display:: Volume 188, Issue 5 (2020)
Year:: 2020
Volume:: 188
Issue:: 5
Issue Sort Value:: 2020-0188-0005-0000
Page Start:: e68
Page End:: e72
Publication Date:: 2019-11-13
Subjects:: eosinophil -- hypereosinophilic syndrome -- interferon alpha -- L‐HES
Hematology -- Periodicals
Blood -- Diseases -- Periodicals
616.15
Journal URLs:: http://www.blacksci.co.uk/%7Ecgilib/jnlpage.bin?Journal=bjh&File=bjh&Page=aims ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1365-2141 ↗
http://onlinelibrary.wiley.com/ ↗
DOI:: 10.1111/bjh.16332 ↗
Languages:: English
ISSNs:: 0007-1048
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 2309.000000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 21691.xml